Medicamen Biotech Quarterly Results for Trading Insights

In Sept 2025, Medicamen Biotech (MEDICAMEQ) reported revenue ₹48 Cr and net profit ₹2 Cr — revenue +6.7% YoY. For annual financials, live price and key ratios, visit MEDICAMEQ stock overview.

Latest Quarter Net Profit
₹2 Cr
QSept 2025
Quarterly Results

MEDICAMEQ Quarterly Results — Revenue, Profit & EPS Highlights

Medicamen Biotech latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Compare with MEDICAMEQ intrinsic value calculation to assess whether the stock is under or overvalued.

  • Revenue of ₹48 Cr in Sept 2025 (+37.1% vs Mar 2025, +6.7% vs Sept 2024)
  • Net Profit of ₹2 Cr in Sept 2025 (+0.0% vs Mar 2025, +100.0% vs Sept 2024)
  • EBITDA of ₹6 Cr in Sept 2025 (+50.0% vs Mar 2025)
  • Operating Margin of 11.0% in Sept 2025 (+16.0pp vs Mar 2025)
  • Earnings Per Share of ₹1.56 in Sept 2025 (+6.1% vs Mar 2025)

Medicamen Biotech Quarterly Results — Revenue, EBITDA, Net Profit & EPS

MEDICAMEQ quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 48 35 44 47 45 37.1% 6.7%
Net Profit (₹ Cr) 2 2 2 2 1 - -
EBITDA (₹ Cr) 6 4 5 5 6 - -
EPS (₹) 1.56 1.47 1.18 1.21 0.71 - -
Operating Margin (%) 11.0% -5.0% 11.0% 9.0% 12.0% - -

MEDICAMEQ Share Price Trend — 1-Year Movement Across Quarterly Results

Medicamen Biotech 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Analyse MEDICAMEQ FII DII holdings to track promoter, FII and institutional holdings.

Profitability Ratios

Profit Margin 4.2%
EBITDA Margin 12.5%
Operating Margin 11.0%
ROE (Annual) 3.8%

Balance Sheet Highlights

Total Assets ₹297 Cr
Total Equity ₹213 Cr
Current Assets ₹165 Cr
Current Liabilities ₹6 Cr

Cash Flow Analysis

Operating Cash Flow ₹-8 Cr
Investing Cash Flow ₹-1 Cr
Financing Cash Flow ₹-2 Cr
Net Cash Flow ₹-11 Cr

Current Market Data

Current Price ₹240.92
Exchange NSE
Last Updated Apr 13, 2026

Revenue Trend (₹ Cr)

Dec 2025 47
Jun 2025 44
Mar 2025 35
Sept 2025 48

Net Profit Trend (₹ Cr)

Dec 2025 2
Jun 2025 2
Mar 2025 2
Sept 2025 2

Operating Margin Trend (%)

Dec 2025 9.0%
Jun 2025 11.0%
Mar 2025 -5.0%
Sept 2025 11.0%

MEDICAMEQ vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Medicamen Biotech latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹396,418.12 Cr 1652.2 14,875 3,125 +10.8% - 21.0% 127.1
Divis Laboratories
Sept 2025 		₹162,373.86 Cr 6070.0 2,860 689 +7.1% - 24.1% 233.7
Torrent Pharmaceuti…
Sept 2025 		₹140,630.85 Cr 4181.0 3,219 591 +11.3% - 18.4% 238.4
Lupin
Sept 2025 		₹106,664.75 Cr 2315.1 6,921 1,485 +23.2% - 21.5% 71.5
Dr Reddys Laborator…
Sept 2025 		₹102,844.71 Cr 1235.9 9,135 1,337 +1.1% - 14.6% 76.4
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores